Literature DB >> 23881491

Heparin sensing: blue-chip binding.

Zachary Shriver, Ram Sasisekharan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23881491      PMCID： PMC3983845          DOI： 10.1038/nchem.1701

Source DB:  PubMed          Journal:  Nat Chem        ISSN： 1755-4330            Impact factor:   24.427


× No keyword cloud information.
  15 in total

Review 1.  Molecular diversity of heparan sulfate.

Authors:  J D Esko; U Lindahl
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Heparan sulfate proteoglycan expression in human lung-cancer cells.

Authors:  K Nackaerts; E Verbeken; G Deneffe; B Vanderschueren; M Demedts; G David
Journal:  Int J Cancer       Date:  1997-06-20       Impact factor: 7.396

3.  Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.

Authors:  Marco Guerrini; Daniela Beccati; Zachary Shriver; Annamaria Naggi; Karthik Viswanathan; Antonella Bisio; Ishan Capila; Jonathan C Lansing; Sara Guglieri; Blair Fraser; Ali Al-Hakim; Nur Sibel Gunay; Zhenqing Zhang; Luke Robinson; Lucinda Buhse; Moheb Nasr; Janet Woodcock; Robert Langer; Ganesh Venkataraman; Robert J Linhardt; Benito Casu; Giangiacomo Torri; Ram Sasisekharan
Journal:  Nat Biotechnol       Date:  2008-04-23       Impact factor: 54.908

Review 4.  Production and chemical processing of low molecular weight heparins.

Authors:  R J Linhardt; N S Gunay
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

5.  Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III.

Authors:  D H Atha; J C Lormeau; M Petitou; R D Rosenberg; J Choay
Journal:  Biochemistry       Date:  1987-10-06       Impact factor: 3.162

6.  Mallard blue: a high-affinity selective heparin sensor that operates in highly competitive media.

Authors:  Stephen M Bromfield; Anna Barnard; Paola Posocco; Maurizio Fermeglia; Sabrina Pricl; David K Smith
Journal:  J Am Chem Soc       Date:  2013-02-13       Impact factor: 15.419

7.  Contaminated heparin associated with adverse clinical events and activation of the contact system.

Authors:  Takashi Kei Kishimoto; Karthik Viswanathan; Tanmoy Ganguly; Subbiah Elankumaran; Sean Smith; Kevin Pelzer; Jonathan C Lansing; Nammalwar Sriranganathan; Ganlin Zhao; Zoya Galcheva-Gargova; Ali Al-Hakim; Gregory Scott Bailey; Blair Fraser; Sucharita Roy; Thomas Rogers-Cotrone; Lucinda Buhse; Mark Whary; James Fox; Moheb Nasr; Gerald J Dal Pan; Zachary Shriver; Robert S Langer; Ganesh Venkataraman; K Frank Austen; Janet Woodcock; Ram Sasisekharan
Journal:  N Engl J Med       Date:  2008-04-23       Impact factor: 91.245

Review 8.  Heparin pharmacokinetics and pharmacodynamics.

Authors:  R J Kandrotas
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

9.  Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.

Authors:  U Lindahl; G Bäckström; L Thunberg; I G Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

10.  Structural analysis of bikunin glycosaminoglycan.

Authors:  Lianli Chi; Jeremy J Wolff; Tatiana N Laremore; Odile F Restaino; Jin Xie; Chiara Schiraldi; Toshihiko Toida; I Jonathan Amster; Robert J Linhardt
Journal:  J Am Chem Soc       Date:  2008-02-05       Impact factor: 15.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.